Patents Assigned to TAKEDA PHARMACEUTICAL COMAPANY LIMITED
  • STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS
    Publication number: 20230130866
    Abstract: The present invention relates to formulations of ADAMTS13 with enhanced or desirable properties. As such, the invention provides liquid and lyophilized formulations of ADAMTS13 that are suitable for pharmaceutical administration. Among other aspects, the present invention also provides methods of treating various diseases and conditions related to VWF and/or ADAMTS13 dysfunction in a subject. Also provided herein are kits comprising ADAMTS13 formulations useful for the treatment of various diseases and conditions.
    Type: Application
    Filed: December 23, 2022
    Publication date: April 27, 2023
    Applicant: TAKEDA PHARMACEUTICAL COMAPANY LIMITED
    Inventors: Peter MATTHIESSEN, Peter L. TURECEK, Hans-Peter Schwarz